These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 21819195

  • 1. Interobserver variability in the interpretation of computed tomography following aneurysmal subarachnoid hemorrhage.
    Ibrahim GM, Weidauer S, Macdonald RL.
    J Neurosurg; 2011 Dec; 115(6):1191-6. PubMed ID: 21819195
    [Abstract] [Full Text] [Related]

  • 2. Attributing hypodensities on CT to angiographic vasospasm is not sensitive and unreliable.
    Ibrahim GM, Weidauer S, Vatter H, Raabe A, Macdonald RL.
    Stroke; 2012 Jan; 43(1):109-12. PubMed ID: 21998061
    [Abstract] [Full Text] [Related]

  • 3. Volumetric analysis of subarachnoid hemorrhage: assessment of the reliability of two computerized methods and their comparison with other radiographic scales.
    Jiménez-Roldán L, Alén JF, Gómez PA, Lobato RD, Ramos A, Munarriz PM, Lagares A.
    J Neurosurg; 2013 Jan; 118(1):84-93. PubMed ID: 22998059
    [Abstract] [Full Text] [Related]

  • 4. Dissociation of vasospasm-related morbidity and outcomes in patients with aneurysmal subarachnoid hemorrhage treated with clazosentan: a meta-analysis of randomized controlled trials.
    Shen J, Pan JW, Fan ZX, Xiong XX, Zhan RY.
    J Neurosurg; 2013 Jul; 119(1):180-9. PubMed ID: 23641823
    [Abstract] [Full Text] [Related]

  • 5. Thick and Diffuse Subarachnoid Blood as a Treatment Effect Modifier of Clazosentan After Subarachnoid Hemorrhage.
    Mayer SA, Aldrich EF, Bruder N, Hmissi A, Macdonald RL, Viarasilpa T, Marr A, Roux S, Higashida RT.
    Stroke; 2019 Oct; 50(10):2738-2744. PubMed ID: 31394993
    [Abstract] [Full Text] [Related]

  • 6. Preventive Effect of Clazosentan against Cerebral Vasospasm after Clipping Surgery for Aneurysmal Subarachnoid Hemorrhage in Japanese and Korean Patients.
    Fujimura M, Joo JY, Kim JS, Hatta M, Yokoyama Y, Tominaga T.
    Cerebrovasc Dis; 2017 Oct; 44(1-2):59-67. PubMed ID: 28463833
    [Abstract] [Full Text] [Related]

  • 7. Randomised trial of clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid hemorrhage undergoing surgical clipping (CONSCIOUS-2).
    Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, Vajkoczy P, Wanke I, Bach D, Frey A, Marr A, Roux S, Kassell N.
    Acta Neurochir Suppl; 2013 Oct; 115():27-31. PubMed ID: 22890639
    [Abstract] [Full Text] [Related]

  • 8. Clazosentan: prevention of cerebral vasospasm and the potential to overcome infarction.
    Beck J, Raabe A.
    Acta Neurochir Suppl; 2011 Oct; 110(Pt 2):147-50. PubMed ID: 21125461
    [Abstract] [Full Text] [Related]

  • 9. A comparison of 3 radiographic scales for the prediction of delayed ischemia and prognosis following subarachnoid hemorrhage.
    Kramer AH, Hehir M, Nathan B, Gress D, Dumont AS, Kassell NF, Bleck TP.
    J Neurosurg; 2008 Aug; 109(2):199-207. PubMed ID: 18671630
    [Abstract] [Full Text] [Related]

  • 10. Impact of systemic inflammatory response syndrome on vasospasm, cerebral infarction, and outcome after subarachnoid hemorrhage: exploratory analysis of CONSCIOUS-1 database.
    Tam AK, Ilodigwe D, Mocco J, Mayer S, Kassell N, Ruefenacht D, Schmiedek P, Weidauer S, Pasqualin A, Macdonald RL.
    Neurocrit Care; 2010 Oct; 13(2):182-9. PubMed ID: 20593247
    [Abstract] [Full Text] [Related]

  • 11. Method of aneurysm treatment does not affect clot clearance after aneurysmal subarachnoid hemorrhage.
    Ibrahim GM, Vachhrajani S, Ilodigwe D, Kassell NF, Mayer SA, Ruefenacht D, Schmiedek P, Weidauer S, Pasqualin A, Macdonald RL.
    Neurosurgery; 2012 Jan; 70(1):102-9; discussion 109. PubMed ID: 21788917
    [Abstract] [Full Text] [Related]

  • 12. Early predictors of prolonged stay in a critical care unit following aneurysmal subarachnoid hemorrhage.
    Witiw CD, Ibrahim GM, Fallah A, Macdonald RL.
    Neurocrit Care; 2013 Jun; 18(3):291-7. PubMed ID: 23371849
    [Abstract] [Full Text] [Related]

  • 13. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial.
    Macdonald RL, Kassell NF, Mayer S, Ruefenacht D, Schmiedek P, Weidauer S, Frey A, Roux S, Pasqualin A, CONSCIOUS-1 Investigators.
    Stroke; 2008 Nov; 39(11):3015-21. PubMed ID: 18688013
    [Abstract] [Full Text] [Related]

  • 14. Electrocardiographic changes predict angiographic vasospasm after aneurysmal subarachnoid hemorrhage.
    Ibrahim GM, Macdonald RL.
    Stroke; 2012 Aug; 43(8):2102-7. PubMed ID: 22678087
    [Abstract] [Full Text] [Related]

  • 15. Impact of global cerebral atrophy on clinical outcome after subarachnoid hemorrhage.
    Tam AK, Kapadia A, Ilodigwe D, Li Z, Schweizer TA, Macdonald RL.
    J Neurosurg; 2013 Jul; 119(1):198-206. PubMed ID: 23662822
    [Abstract] [Full Text] [Related]

  • 16. The effect of endothelin receptor antagonists on vasospasm following aneurysmal subarachnoid hemorrhage.
    Komotar RJ, Starke RM, Connolly ES.
    Neurosurgery; 2011 Dec; 69(6):N13-4. PubMed ID: 22067343
    [No Abstract] [Full Text] [Related]

  • 17. Endothelin receptor antagonists for aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update.
    Vergouwen MD, Algra A, Rinkel GJ.
    Stroke; 2012 Oct; 43(10):2671-6. PubMed ID: 22871682
    [Abstract] [Full Text] [Related]

  • 18. Patient phenotypes associated with outcomes after aneurysmal subarachnoid hemorrhage: a principal component analysis.
    Ibrahim GM, Morgan BR, Macdonald RL.
    Stroke; 2014 Mar; 45(3):670-6. PubMed ID: 24425125
    [Abstract] [Full Text] [Related]

  • 19. Clazosentan for Aneurysmal Subarachnoid Hemorrhage: An Updated Meta-Analysis with Trial Sequential Analysis.
    Cho SS, Kim SE, Kim HC, Kim WJ, Jeon JP.
    World Neurosurg; 2019 Mar; 123():418-424.e3. PubMed ID: 30508597
    [Abstract] [Full Text] [Related]

  • 20. Symptomatic Vasospasm Refractory to Clazosentan after Subarachnoid Hemorrhage of Ruptured Vertebral Artery Dissecting Aneurysm: Clinical Implications from Two Contrasting Cases.
    Yoshida Y, Mutoh T, Moroi J, Ishikawa T.
    Medicina (Kaunas); 2024 Sep 20; 60(9):. PubMed ID: 39336584
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.